AIMZ Investment Advisors, LLC
Source: SEC Form 13F · as of Mar 2026AIMZ Investment Advisors, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $76.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$76.9M
| Company | Shares | Value |
|---|---|---|
| VRTXVERTEX PHARMACEUTICALS INC / MA | 19,956 | $8.9M |
| GILDGILEAD SCIENCES, INC. | 61,338 | $8.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 9,491 | $7.3M |
| TEVATeva Pharmaceutical Industries Limited | 214,978 | $6.5M |
| INCYIncyte Corp. | 65,158 | $6.1M |
| AZNASTRAZENECA PLC | 27,296 | $5.4M |
| AMGNAMGEN INC | 12,884 | $4.5M |
| GMABGenmab A/S | 160,910 | $4.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 15,159 | $4.1M |
| JNJJOHNSON & JOHNSON | 14,128 | $3.5M |
| ABBVAbbVie Inc. | 15,498 | $3.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 59,334 | $3.3M |
| BMYBRISTOL MYERS SQUIBB CO | 52,522 | $3.2M |
| MRKMerck & Co., Inc. | 25,324 | $3.0M |
| NVSNovartis AG | 13,334 | $2.0M |
| ABTABBOTT LABORATORIES | 16,373 | $1.7M |
| LLYELI LILLY & Co | 611 | $562K |
| PFEPFIZER INC | 13,930 | $391K |
| MYGNMYRIAD GENETICS INC | 37,210 | $167K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.